Vertex Pharmaceuticals Incorporated (VRTX)

NASDAQ: VRTX · Real-Time Price · USD

499.17

+38.30 (8.31%)

At close: Mar 10, 2026, 4:00 PM EDT

500.25

+1.08 (0.22%)

After-hours: Mar 10, 2026, 7:52 PM EDT

Vertex Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	12,001	11,020	9,869	8,931	7,574
Revenue Growth (YoY)	8.90%	11.66%	10.51%	17.91%	22.06%
Cost of Revenue	1,651	1,531	1,262	1,080	904.2
Gross Profit	10,350	9,490	8,607	7,850	6,670
Selling, General & Admin	1,753	1,464	1,137	944.7	840.1
Research & Development	4,043	8,259	3,690	2,656	3,051
Other Operating Expenses	381.1	-0.5	-51.6	-57.5	-3.1
Total Operating Expenses	6,177	9,723	4,775	3,543	3,888
Operating Income	4,173	-232.9	3,832	4,307	2,782
Interest Income	490.9	598.1	614.7	144.6	4.9
Interest Expense	-13.3	-30.6	-44.1	-54.8	-61.5
Other Non-Operating Income (Expense)	-7.7	-86.1	-22.8	-164.8	4.9
Total Non-Operating Income (Expense)	469.9	481.4	547.8	-75	-51.7
Pretax Income	4,643	248.5	4,380	4,232	2,730
Provision for Income Taxes	690	784.1	760.2	910.4	388.3
Net Income	3,953	-535.6	3,620	3,322	2,342
Net Income to Common	3,953	-535.6	3,620	3,322	2,342
Net Income Growth	-	-	8.96%	41.84%	-13.63%
Shares Outstanding (Basic)	256	258	258	256	258
Shares Outstanding (Diluted)	258	258	261	259	260
Shares Change (YoY)	0.04%	-1.00%	0.54%	-0.31%	-1.33%
EPS (Basic)	15.46	-2.08	14.05	12.97	9.09
EPS (Diluted)	15.32	-2.08	13.89	12.82	9.01
EPS Growth	-	-	8.35%	42.29%	-12.44%
Free Cash Flow	3,194	-790.3	3,337	3,925	2,409
Free Cash Flow Growth	-	-	-14.99%	62.97%	-19.55%
Free Cash Flow Per Share	12.38	-3.06	12.81	15.15	9.27
Gross Margin	86.24%	86.11%	87.21%	87.90%	88.06%
Operating Margin	34.77%	-2.11%	38.83%	48.23%	36.73%
Profit Margin	32.94%	-4.86%	36.68%	37.20%	30.92%
FCF Margin	26.61%	-7.17%	33.81%	43.95%	31.80%
EBITDA	4,383	-25.7	4,013	4,456	2,908
EBITDA Margin	36.52%	-0.23%	40.66%	49.89%	38.39%
EBIT	4,173	-232.9	3,832	4,307	2,782
EBIT Margin	34.77%	-2.11%	38.83%	48.23%	36.73%
Effective Tax Rate	14.86%	315.53%	17.36%	21.51%	14.22%

Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q